A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression

Recruiting Phase 1 Phase 2 Interventional Study
Depression
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 64
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Other
Participants needed
10 (estimated)
Sponsor
Juliana Zambrano, MD, MPH · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1\. Self-identifying Latinx, Spanish-speaking 2. Adults 18-64 years 3. Meet DSM-5 criteria for major depressive disorder as evaluated by study clinician 4. Montgomery-Asberg depression scale (MADRS) score of 20 or above at baseline 4. Participants must have an MGB psychiatrist a…
Contacts

Juliana Zambrano, MD

617-726-2000

JZAMBRANO2@mgh.harvard.edu

CONTACT